Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 6Recruiting 5Withdrawn 2Unknown 2Terminated 2

Sponsor Class

NIH 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 2Other 1

Conditions

Prostatic Neoplasms 2Sexual Dysfunction, Physiological 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × High-Intensity Focused Ultrasound Ablation × Clear all
NCT00987675 2013-08-26

High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
26 enrolled
Genitourinary

Prostatic Neoplasms

NCT00988130 2013-08-26

High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
26 enrolled
GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡